Episode Details

As the world saw the coronavirus vaccines get developed and administered within a year of the first confirmed case, many may be wondering how the healthcare sector at large was able to achieve such an incredible feat. Are we seeing this level of innovation in other areas of healthcare today? And will it be sustainable going forward? On this episode of Disruptive Forces, Anu Rajakumar speaks with Jeffrey Ferrell and Jeremy Lack, partners at Athyrium Capital Management, a specialized healthcare asset manager, to share more insight on the vaccines' speed to market, the various innovation trends happening in healthcare today, and what they anticipate we will continue to see going forward.

This general market summary and the opinions and beliefs expressed in this podcast are provided for general informational purposes only. Nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security, and the views and beliefs expressed are not intended to predict or guarantee the future performance of any individual security, market sector or the markets generally. This presentation is general in nature and is not directed to any category of investors and should not be regarded as individualized, a recommendation, investment advice or a suggestion to engage in or refrain from any investment-related course of action. Investment decisions and the appropriateness of this presentation should be made based on an investor's individual objectives and circumstances and in consultation with his or her advisors. Information is obtained from sources deemed reliable, but there is no representation or warranty as to its accuracy, completeness or reliability, and has not been independently verified. All information, opinions and beliefs set forth in this presentation are current as of the date of this presentation and are subject to change without notice. Neuberger Berman and Athyrium Capital Management do not undertake to advise you of any change in the opinions and beliefs or the information contained in this presentation. Any views or opinions expressed may not reflect those of the firm as a whole. Neuberger Berman or Athyrium Capital Management may issue presentations or have opinions that are inconsistent with, and reach different conclusions from, this presentation. Certain statements herein reflect the subjective opinion and judgment of Neuberger Berman and Athyrium Capital Management and cannot be independently verified. Such opinions and judgments are subject to change. There can be no assurance that any predictions or projections will be realized. With respect to any trends identified herein, there can be no assurance any such trends will ultimately be realized. No representation is made that any investment process, investment objectives, goals or risk management techniques discussed herein will or are likely to be achieved or successful.

Any forward-looking opinions, beliefs, estimates, assumptions, outlooks, projections, assessments, or similar statements (collectively, "Statements"), constitute only subjective views, estimations or intentions, should not be relied on, are subject to change due to many factors, including fluctuating market conditions and economic factors. Such Statements involve inherent risks, many of which cannot be predicted or quantified and are beyond our control. Future evidence and actual results could differ materially from those set forth in, contemplated by, or underlying these Statements, which are subject to change without notice. Considering the foregoing, there can be no assurance and no representation is given that these Statements are now, or will prove to be, accurate or complete. Neuberger Berman and Athyrium Capital Management undertake no responsibility or obligation to revise or update such Statements.

Products and services offered by Neuberger Berman or Athyrium Capital Management may not be available in all juris